FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1640201689> ?p ?o ?g. }

• W1640201689 abstract "Human papillomaviruses (HPV) are the etiological agents of cervical cancer. The viral E7 protein plays a crucial role in viral oncogenesis. Many strategies have been explored to block the E7 oncoprotein activity. The single-chain variable antibody fragments (scFvs) are valuable tools in cancer immunotherapy and can be used as intracellular antibodies to knock out specific protein functions. For both in vivo and in vitro employment, the scFv intrinsic solubility and stability are important to achieve long-lasting effects. Here we report the characterization in terms of reactivity, solubility and thermal stability of three anti-HPV16 E7 scFvs. We have also analysed the scFv43 sequence with the aim of improving stability and then activity of the antibody, previously shown to have antiproliferative activity when expressed in HPV16-positive cells.The three anti-HPV16 E7 scFv 32, 43 51 were selected from the ETH-2 phage-display library. Thermal stability was evaluated with ELISA by determining the residual activity of each purified scFv against the recombinant HPV16 E7, after incubation in the presence of human seroalbumine for different time-intervals at different temperatures. Sequence analysis of the scFvs was performed with BLAST and CLUSTALL programs. The scFv43 aminoacid changes were reverted back to the consensus sequence from the immunoglobuline database by site-directed mutagenesis. ScFv solubility was evaluated with Western blotting by determining their relative amounts in the soluble and insoluble fractions of both prokaryotic and eukaryotic systems.ScFv51 was the most thermally stable scFv considered. Sequence analysis of the most reactive scFv43 has evidenced 2 amino acid changes possibly involved in molecule stability, in the VH and VL CDR3 regions respectively. By mutagenesis, two novel scFv43-derived scFvs were obtained, scFv43 M1 and M2. ScFv43 M2 showed to have improved thermal stability and solubility in comparison with the parental scFv43.The characterization of 5 specific anti-HPV16 E7 scFvs shows features important for their activity in vivo. ScFv43 M2 shows higher thermal stability with respect to the parental scFv43, and scFv51 shows high stability and solubility. These properties make the 2 scFvs the best candidates to be tested for anti-E7 activity in vivo." @default.
• W1640201689 created "2016-06-24" @default.
• W1640201689 creator A5015312368 @default.
• W1640201689 creator A5056876554 @default.
• W1640201689 creator A5079974622 @default.
• W1640201689 date "2007-01-31" @default.
• W1640201689 modified "2023-10-17" @default.
• W1640201689 title "Characterization of antibodies in single-chain format against the E7 oncoprotein of the Human papillomavirus type 16 and their improvement by mutagenesis" @default.
• W1640201689 cites W1519261202 @default.
• W1640201689 cites W1565859610 @default.
• W1640201689 cites W1572496212 @default.
• W1640201689 cites W1810166418 @default.
• W1640201689 cites W1967933229 @default.
• W1640201689 cites W1968704981 @default.
• W1640201689 cites W1985748128 @default.
• W1640201689 cites W1993575340 @default.
• W1640201689 cites W2005110237 @default.
• W1640201689 cites W2010533241 @default.
• W1640201689 cites W2012088688 @default.
• W1640201689 cites W2013580208 @default.
• W1640201689 cites W2020610816 @default.
• W1640201689 cites W2020905623 @default.
• W1640201689 cites W2022228265 @default.
• W1640201689 cites W2028123682 @default.
• W1640201689 cites W2039753129 @default.
• W1640201689 cites W2039934202 @default.
• W1640201689 cites W2054583662 @default.
• W1640201689 cites W2056558465 @default.
• W1640201689 cites W2062793526 @default.
• W1640201689 cites W2065142199 @default.
• W1640201689 cites W2075683739 @default.
• W1640201689 cites W2076848430 @default.
• W1640201689 cites W2089204594 @default.
• W1640201689 cites W2098765233 @default.
• W1640201689 cites W2101196984 @default.
• W1640201689 cites W2127126118 @default.
• W1640201689 cites W2133636335 @default.
• W1640201689 cites W2155126687 @default.
• W1640201689 cites W2160034474 @default.
• W1640201689 cites W2163543551 @default.
• W1640201689 cites W2320202233 @default.
• W1640201689 cites W2749679400 @default.
• W1640201689 doi "https://doi.org/10.1186/1471-2407-7-25" @default.
• W1640201689 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1797048" @default.
• W1640201689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17266749" @default.
• W1640201689 hasPublicationYear "2007" @default.
• W1640201689 type Work @default.
• W1640201689 sameAs 1640201689 @default.
• W1640201689 citedByCount "17" @default.
• W1640201689 countsByYear W16402016892013 @default.
• W1640201689 countsByYear W16402016892014 @default.
• W1640201689 countsByYear W16402016892016 @default.
• W1640201689 countsByYear W16402016892017 @default.
• W1640201689 countsByYear W16402016892019 @default.
• W1640201689 countsByYear W16402016892020 @default.
• W1640201689 countsByYear W16402016892021 @default.
• W1640201689 crossrefType "journal-article" @default.
• W1640201689 hasAuthorship W1640201689A5015312368 @default.
• W1640201689 hasAuthorship W1640201689A5056876554 @default.
• W1640201689 hasAuthorship W1640201689A5079974622 @default.
• W1640201689 hasBestOaLocation W16402016891 @default.
• W1640201689 hasConcept C104317684 @default.
• W1640201689 hasConcept C153911025 @default.
• W1640201689 hasConcept C159047783 @default.
• W1640201689 hasConcept C159654299 @default.
• W1640201689 hasConcept C16318435 @default.
• W1640201689 hasConcept C185592680 @default.
• W1640201689 hasConcept C186268636 @default.
• W1640201689 hasConcept C202751555 @default.
• W1640201689 hasConcept C2780868878 @default.
• W1640201689 hasConcept C40767141 @default.
• W1640201689 hasConcept C501734568 @default.
• W1640201689 hasConcept C54355233 @default.
• W1640201689 hasConcept C55493867 @default.
• W1640201689 hasConcept C86803240 @default.
• W1640201689 hasConceptScore W1640201689C104317684 @default.
• W1640201689 hasConceptScore W1640201689C153911025 @default.
• W1640201689 hasConceptScore W1640201689C159047783 @default.
• W1640201689 hasConceptScore W1640201689C159654299 @default.
• W1640201689 hasConceptScore W1640201689C16318435 @default.
• W1640201689 hasConceptScore W1640201689C185592680 @default.
• W1640201689 hasConceptScore W1640201689C186268636 @default.
• W1640201689 hasConceptScore W1640201689C202751555 @default.
• W1640201689 hasConceptScore W1640201689C2780868878 @default.
• W1640201689 hasConceptScore W1640201689C40767141 @default.
• W1640201689 hasConceptScore W1640201689C501734568 @default.
• W1640201689 hasConceptScore W1640201689C54355233 @default.
• W1640201689 hasConceptScore W1640201689C55493867 @default.
• W1640201689 hasConceptScore W1640201689C86803240 @default.
• W1640201689 hasIssue "1" @default.
• W1640201689 hasLocation W16402016891 @default.
• W1640201689 hasLocation W16402016892 @default.
• W1640201689 hasLocation W16402016893 @default.
• W1640201689 hasLocation W16402016894 @default.
• W1640201689 hasOpenAccess W1640201689 @default.
• W1640201689 hasPrimaryLocation W16402016891 @default.
• W1640201689 hasRelatedWork W1024660077 @default.
• W1640201689 hasRelatedWork W1539317970 @default.
• W1640201689 hasRelatedWork W2085919721 @default.
• W1640201689 hasRelatedWork W2103445103 @default.

• next